CHEK2 and breast cancer: A large study of nearly 113,000 women, including over 60,000 patients with BC, identified gene alterations in ATM, BRCA1, BRCA2, PALB2, BARD1, RAD51C, RAD51D, Chk2, and TP53 as significant risk factors for BC.